Skip to main content
. 2022 Nov 19;55(1):18–31. doi: 10.1007/s11239-022-02732-3

Fig. 3.

Fig. 3

Risk factors for death among SVT patients with COVID-19 (A) or who received COVID-19 vaccines (B). ALT alanine aminotransferase, AST aspartate aminotransferase, APTT activated partial thromboplastin time, COVID-19 coronavirus disease 2019, CIs confidence intervals, CRP C-reactive protein, CVT cerebrovascular thrombosis, IVIG intravenous immunoglobulin, OR odds ratios, PLT platelet, PT prothrombin time, PE pulmonary embolism, SVT splanchnic vein thrombosis, WBC white blood cell